Search - tctmd.com

Displaying 21 - 40 of 66

Sort: Relevancy | Date

Presentation TCT 2018

Optimal Medical Therapy of Patients With Critical Limb Ischemia

Presenter: Ehrin J. Armstrong, Sahil A. Parikh, Douglas E. Drachman

September 22, 2018

Presentation TCT 2018

Optimal Medical Therapy With and Without Coronary Revascularization: Which Drugs Matter? Symptoms, Ischemia, or Prognosis? And Magnitude of Impact

Presenter: David J. Cohen, Sunil V. Rao, David J. Maron

September 22, 2018

News Conference News TCT 2018

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Michael O'Riordan

September 21, 2018

News Daily News

PCI in Nonagenarians Rising as Focus Shifts to Frailty Over Age

Yael L. Maxwell

September 18, 2018

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

News Daily News

TAVR Learning Curve, Volume-Outcome Relationship Highlighted in International Registry

Todd Neale

September 11, 2018

News Conference News PCR London Valves 2018

MITRA-FR in the Hot Seat as Experts Debate Impact on Guidelines and Practice

Shelley Wood

September 10, 2018

News Conference News ESC 2018

FFRCT Shifts Patient Management, Linked to Better 90-Day Outcomes: ADVANCE Registry

Caitlin E. Cox

September 07, 2018

News Conference News ESC 2018

COMMANDER HF: Low-Dose Rivaroxaban Flops in Heart Failure

Todd Neale

August 27, 2018

News Conference News ESC 2018

GLOBAL LEADERS: Ticagrelor Monotherapy Fails to Beat Conventional DAPT After PCI

Michael O'Riordan

August 27, 2018

News Conference News ESC 2018

MITRA-FR: No Benefit of MitraClip in Functional MR

Shelley Wood

August 27, 2018

News Conference News ESC 2018

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Michael O'Riordan

August 26, 2018

News Conference News ESC 2018

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

Shelley Wood

August 26, 2018

News Conference News ESC 2018

FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice

Todd Neale

August 26, 2018

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

News Opinion Fellow Talk

Three Lessons Learned in Using Myocardial Viability to Guide Multivessel Revascularization

Yashasvi Chugh, MD

August 16, 2018

News Daily News

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Caitlin E. Cox

August 15, 2018

News Daily News

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Michael O'Riordan

August 09, 2018

News Daily News

Discharge Against Medical Advice After PCI Rare but Deadly

Michael O'Riordan

July 17, 2018

News Daily News

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

Michael O'Riordan

July 06, 2018

Advertisement

Optimal Medical Therapy of Patients With Critical Limb Ischemia

Optimal Medical Therapy With and Without Coronary Revascularization: Which Drugs Matter? Symptoms, Ischemia, or Prognosis? And Magnitude of Impact

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

PCI in Nonagenarians Rising as Focus Shifts to Frailty Over Age

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

TAVR Learning Curve, Volume-Outcome Relationship Highlighted in International Registry

MITRA-FR in the Hot Seat as Experts Debate Impact on Guidelines and Practice

FFRCT Shifts Patient Management, Linked to Better 90-Day Outcomes: ADVANCE Registry

COMMANDER HF: Low-Dose Rivaroxaban Flops in Heart Failure

GLOBAL LEADERS: Ticagrelor Monotherapy Fails to Beat Conventional DAPT After PCI

MITRA-FR: No Benefit of MitraClip in Functional MR

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Three Lessons Learned in Using Myocardial Viability to Guide Multivessel Revascularization

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Discharge Against Medical Advice After PCI Rare but Deadly

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content